Russia’s Cancer Vaccine Enteromix Displays 100 Per Cent Efficacy In Clinical Trials

  • Post author:
  • Post category:Blog

Enteromix, a personalized mRNA cancer vaccine, showed 100% efficacy and safety in trials. Developed by Russian institutes, it awaits Ministry of Health approval for public use.